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1Autopsy studies have demonstrated that around two thirds of all myocardial infarctions are because of plaque rupture, result-
ing in luminal thrombosis.1 Ruptured plaques are characterized by 
a large, lipid-rich necrotic core (NC) with an overlying, thin fibrous 
cap.2 A precursor lesion for rupture, termed a thin-cap fibroath-
eroma (TCFA), displays similar plaque compositional features to 
ruptured plaques. As such, imaging modalities that can identify 
TCFAs before rupture are of considerable clinical importance.
See Clinical Perspective
See Editorial by Mintz
Virtual-histology intravascular ultrasound (VH-IVUS) is an 
invasive imaging modality that uses radiofrequency ultrasound 
backscatter data to identify plaque components, including NC, 
calcification, fibrous, and fibrofatty tissue. In ex vivo studies, 
VH-IVUS has predictive accuracies of >93.5% to characterize 
coronary plaque composition3 and a diagnostic accuracy of 76% 
for TCFA.4 Furthermore, despite VH-IVUS not having the reso-
lution to measure a thin fibrous cap, multiple prospective stud-
ies demonstrate that VH-IVUS–defined TCFA (VH-TCFA) are 
associated with future major adverse cardiovascular events,5–7 
confirming their biological importance. Nevertheless, overall 
event rates attributable to each high-risk plaque in these stud-
ies were low (<10%) and the prevalence of VH-TCFA in vivo 
far exceeded that observed in autopsy studies,8 suggesting that 
VH-IVUS may overestimate TCFA prevalence.
Background—Although rupture of thin-cap fibroatheroma (TCFA) underlies most myocardial infarctions, reliable TCFA 
identification remains challenging. Virtual-histology intravascular ultrasound (VH-IVUS) and optical coherence 
tomography (OCT) can assess tissue composition and classify plaques. However, direct comparisons between VH-IVUS 
and OCT are lacking and it remains unknown whether combining these modalities improves TCFA identification.
Methods and Results—Two hundred fifty-eight regions-of-interest were obtained from autopsied human hearts, with plaque 
composition and classification assessed by histology and compared with coregistered ex vivo VH-IVUS and OCT. Sixty-
seven regions-of-interest were classified as fibroatheroma on histology, with 22 meeting criteria for TCFA. On VH-
IVUS, plaque (10.91±4.82 versus 8.42±4.57 mm2; P=0.01) and necrotic core areas (1.59±0.99 versus 1.03±0.85 mm2; 
P=0.02) were increased in TCFA versus other fibroatheroma. On OCT, although minimal fibrous cap thickness was 
similar (71.8±44.1 μm versus 72.6±32.4; P=0.30), the number of continuous frames with fibrous cap thickness ≤85 
μm was higher in TCFA (6.5 [1.75–11.0] versus 2.0 [0.0–7.0]; P=0.03). Maximum lipid arc on OCT was an excellent 
discriminator of fibroatheroma (area under the curve, 0.92; 95% confidence interval, 0.87–0.97) and TCFA (area under 
the curve, 0.86; 95% confidence interval, 0.81–0.92), with lipid arc ≥80° the optimal cut-off value. Using existing criteria, 
the sensitivity, specificity, and diagnostic accuracy for TCFA identification was 63.6%, 78.1%, and 76.5% for VH-IVUS 
and 72.7%, 79.8%, and 79.0% for OCT. Combining VH-defined fibroatheroma and fibrous cap thickness ≤85 μm over 3 
continuous frames improved TCFA identification, with diagnostic accuracy of 89.0%.
Conclusions—Both VH-IVUS and OCT can reliably identify TCFA, although OCT accuracy may be improved using lipid arc 
≥80° and fibrous cap thickness ≤85 μm over 3 continuous frames. Combined VH-IVUS/OCT imaging markedly improved 
TCFA identification.  (Circ Cardiovasc Imaging. 2015;8:e003487. DOI: 10.1161/CIRCIMAGING.115.003487.)
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Intravascular optical coherence tomography (OCT) is 
an alternative technique that allows plaque characterization 
using near-infrared light to display high-resolution (≈20 μm) 
images of coronary lesions. Validation studies have suggested 
that OCT has sensitivities around 75% for fibrous, 95% for 
fibrocalcific, and 92% for lipid-rich plaques.9 The high reso-
lution of OCT also has potential to identify plaque features 
not visible on VH-IVUS, including measurement of fibrous 
cap thickness (FCT).10 Although prospective studies are lack-
ing, lipid-rich plaques on OCT are more commonly associated 
with acute coronary syndromes,11 and OCT-defined TCFA are 
more numerous in angiographically mild lesions, an observa-
tion consistent with autopsy data.12
Although clinical studies have used VH-IVUS and OCT 
to describe coronary atherosclerosis, their ability to identify 
TCFA and discriminate TCFA from other fibroatheroma have 
never been directly compared. We assessed VH-IVUS and 
OCT characteristics of advanced lesions, as defined by his-
tology, and identified features of each imaging modality that 
optimally discriminate between TCFA and other fibroather-
oma. We next tested the ability of both VH-IVUS and OCT to 
correctly identify TCFA using existing plaque classification 
definitions and assessed whether refined imaging cut-off val-
ues could improve TCFA identification. Finally, we assessed 
whether combined VH-IVUS/OCT was more accurate for 
TCFA identification than either modality alone.
Methods
Ex Vivo Imaging
The study protocol was approved by the Cambridgeshire Research 
and Ethics Committee (Ref. 07/H0306/123) and consent obtained 
from relatives. Arteries were harvested from human hearts during au-
topsy in consultation with a senior pathologist. Hearts were excluded 
if coronary artery thrombosis was the suspected cause of death. All 
vessels were stored immediately in phosphate-buffered saline at 4°C 
and imaged within 48 hours of death. The left anterior descending 
artery (n=14) was dissected and excised, including ≈40 mm of sur-
rounding tissue to maintain overall structural integrity.4 Side branches 
were ligated and a guide catheter sutured into the left coronary os-
tium. A 0.014″ coronary guidewire (either BMW Universal or Pilot 
50, Abbott Vascular) was advanced permitting delivery of intravas-
cular catheters. The vessel was fixed to a proprietary designed rig 
and prewarmed (to 37°C). Vessels were imaged under pressure–per-
fusion at 100 mm Hg before histological processing. VH-IVUS data 
were acquired using 20-MHz Eagle-Eye Gold catheters (Volcano 
Corporation) at 0.5 mm/s pullback, with radiofrequency data being 
captured on the R wave provided by an ECG signal generator. OCT 
data were acquired by DragonFly C7 catheters (St. Jude Medical) 
using 25.0 mm/s automated pullback. All imaging data were digitally 
stored and exported for offline analysis.
Histological Processing
After imaging, arteries were fixed in 10% buffered formalin for ≥24 
hours. Five millimeter longitudinal intervals were marked along the 
length of the artery as regions-of-interest (ROI). Vessels underwent 
decalcification if necessary using EDTA followed by histological 
processing. Histological sections of 5-μm thickness were then cut at 
400-μm intervals throughout ROI, maintaining proximal and distal 
orientation. Histological sections were stained with hematoxylin-
eosin and Van Gieson and reviewed by an independent, experienced 
cardiac pathologist, blinded to all intracoronary imaging. Reading of 
the histological sections and imaging data was performed in a random 
order. Plaque classification was performed based on the modified 
AHA classification scheme2 as follows. Adaptive intimal thickening 
was plaque with evidence of fibrous tissue but without lipid pools; 
pathological intimal thickening had evidence of extracellular lipid 
accumulation but without a defined NC; fibrocalcific plaques were 
plaques with large areas of calcification with small, or absent, NCs, 
and fibroatheroma were plaques containing necrotic lipid core with 
inflammatory cellular infiltration. A TCFA was defined as any fibro-
atheroma with an FCT <65 μm.
Virtual-Histology Intravascular Ultrasound 
Analysis
VH-IVUS data were analyzed offline using echoPlaque 4.0 (Indec 
Medical Systems) by 2 independent observers blinded to histology 
and OCT. Both luminal and external elastic membrane borders were 
manually corrected for each frame, permitting measurement of gray-
scale IVUS features, including plaque burden and luminal area. Once 
borders were defined, the backscattered ultrasound data were auto-
matically processed, with colors assigned for each tissue component: 
fibrous (dark green), fibrofatty (light green), NC (red), and dense 
calcium (white). VH-defined plaque classification (Figure 1) was 
performed using an established classification system; full details are 
found in the Methods section of Data Supplement.6 A consensus was 
obtained in cases of disagreement and this value used in subsequent 
analysis. Interobserver agreement for VH-defined plaque classifica-
tion was strong (κ=0.84; 95% confidence interval [CI], 0.78–0.90; 
Table I in the Data Supplement).
OCT Analysis
Offline OCT analysis was performed using LightLab Imaging work-
station (St. Jude Medical) by 2 independent observers blinded to 
histology and IVUS. Luminal contours were manually adjusted and 
plaque composition assessed for each frame. Lipid was defined as a 
signal-poor region within a plaque, with poorly delineated borders 
and a fast drop-off in OCT signal, whereas calcium was defined 
as a signal-poor region, but with sharply delineated borders and a 
gradual drop-off in OCT signal.10 Lipid arc (LA) measurements 
were recorded within each frame and mean (LA
mean
) and maximum 
(LA
max
) value calculated. If lipid was present in a frame, minimal 
Figure 1. Plaque classification using virtual-histology intravascu-
lar ultrasound. A–D, Examples of 4 virtual-histology intravascular 
ultrasound plaques (plaque burden >40%), classified as patho-
logical intimal thickening (A), fibrocalcific plaque (B), thick-cap 
fibroatheroma (C), and thin-cap fibroatheroma (D).
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FCT (FCT
min) was measured at its thinnest part 3× times and mean 
value used in subsequent analysis.12 The number of continuous OCT 
frames with FCT
min ≤85 μm was also documented. OCT Plaque clas-
sification was performed according to an international consensus 
statement (Figure 2)10; an OCT-defined fibroatheroma was defined 
as plaque with LA
max
 ≥90°, with an OCT-defined TCFA having an 
FCT
min ≤85 μm, a value ≈20% higher than the histological defini-
tion to account for tissue shrinkage.13 Full details with illustrations 
of OCT plaque classification can be found in the Methods section of 
Data Supplement. Interobserver agreement for OCT plaque classifi-
cation was strong (κ=0.89; 95% CI, 0.83–0.94; Table II in the Data 
Supplement).
Statistical Analysis
Continuous data are expressed as mean±SD, whereas categorical 
data are presented as counts (or percentages). Agreement between 
VH-IVUS and OCT plaque classification observers was quantified 
by Cohen κ test. Plaque composition between lesion subtypes was 
compared using a nested ANOVA or t test where appropriate, as 
changes in plaque morphology may also be affected by differences 
in individuals, rather than differences in plaque morphology. For this, 
a hierarchical tree was created, first nesting each ROI within an ath-
erosclerotic plaque and second with the donor heart itself, as each 
heart only provided 1 artery for the analysis. To assess diagnostic 
ability, the sensitivity, specificity, positive predictive value, negative 
predictive value, and diagnostic accuracy for each imaging modal-
ity were calculated, with corresponding Clopper–Pearson 95% CIs. 
These CIs were adjusted for clustering in the data by dividing the 
sample size by a design effect (which was computed as a function of 
the average number of ROI in each artery and the intracluster correla-
tion coefficient) to obtain an effective sample size on which intervals 
were based. Receiver-operating characteristic curves were calculated 
by plotting sensitivity versus (1 -specificity), allowing calculation of 
area under the curve (AUC). Statistical analyses were performed both 
in SPSS 21.0.0 (SPSS Inc, IBM Computing) and R 2.10.1 (The R 
Foundation for Statistical Computing).
Results
Clinical Demographics
Fourteen human hearts were harvested and imaged. Demo-
graphics of donors are presented in Table 1. Donors ranged in 
age from 47 to 85 years, with 71.4% being male. As athero-
sclerosis is almost uniformly present in this age group, hearts 
were obtained from donors experiencing both cardiovascular 
death and noncardiovascular death, although death because of 
presumed coronary thrombosis was excluded.
ROI Features and Composition
Overall, 1290 mm of coronary artery were analyzed repre-
senting 258 histological ROI, with VH-IVUS available for 
211 (81.8%), OCT for 207 (80.2%), and dual imaging for 
200 (77.5%). VH-IVUS and OCT image sets were matched to 
coregistered histological ROI by an experienced intravascular 
imaging investigator, blinded to final histological plaque clas-
sification. Coregistration was aided by detailed measurements 
taken during ex vivo imaging using fiduciary landmarks, 
including bifurcations, guide catheter location, and prominent 
calcific deposits (Figure 3). By histology, ROI were classi-
fied as adaptive intimal thickening 97 (37.6%), pathological 
intimal thickening 50 (19.4%), fibrocalcific 38 (14.7%), and 
fibroatheroma 73 (28.3%). Of the ROI classified as fibroath-
eroma, 22 met the criteria for TCFA (8.5% of total ROI) with 
mean FCT on histology being 43.0±16.8 μm. All TCFA were 
imaged by both VH-IVUS and OCT. ROI that could not be 
imaged were all located in distal coronary segments and were 
classified as adaptive intimal thickening (66.7%), pathological 
Figure 2. Plaque classification using optical coherence tomog-
raphy. Optical coherence tomographic images illustrating both 
nonatherosclerotic vessel (A) and plaque (B), with evidence of 
focal intimal thickening and loss of layered vessel wall structure 
in (B). C–F, Further examples of fibrous plaque (C), fibrocalcific 
plaque (D), thick-cap fibroatheroma (E), and thin-cap fibroather-
oma (F). Coronary guidewire artifact is denoted by * in all images.
Table 1. Clinical Characteristics of Donors for Autopsy 
Studies
Overall  
(n=14)
CV death 
(n=8)
Non-CV death 
(n=6)
Male, n (%) 10 (71.4) 8 (100.0) 2 (33.3)
Age, y (SD) 71.1 (11.8) 76.8 (9.8) 63.6 (10.3)
Medical comorbidities, n (%)
  Ischemic heart disease 7 (50.0) 6 (75.0) 1 (16.7)
  Cerebrovascular disease 2 (14.3) 1 (12.5) 1 (16.7)
  Extra-cardiac arteriopathy 6 (42.9) 4 (50.0) 2 (33.3)
  Diabetes mellitus 1 (97.1) 1 (12.5) 0 (0.0)
  Hypertension 5 (35.7) 3 (37.5) 2 (33.3)
  Cardiac failure 6 (42.9) 4 (50.0) 2 (33.3)
  CTEPH 3 (21.4) 1 (12.5) 2 (33.3)
CV indicates cardiovascular; and CTEPH, chronic thromboembolic pulmonary 
hypertension.
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intimal thickening (17.5%), fibrocalcific (8.7%), and fibroath-
eroma (7.0%).
We analyzed changes in plaque composition on ROI 
according to histological classification with increasing lesion 
complexity, focusing particularly on features that differ 
between histological TCFA and other fibroatheroma (Tables 2 
and 3). Plaque area and burden on gray-scale IVUS increased 
significantly (P<0.001 using nested ANOVA) as plaques pro-
gressed, associated with increasing areas of fibrous, fibro-
fatty, NC, and dense calcium (P<0.001 using nested ANOVA) 
on VH-IVUS. Plaque area was significantly increased in 
TCFA compared with other fibroatheroma on gray-scale 
IVUS (10.91±4.82 versus 8.42±4.57 mm2; P=0.01), although 
plaque burden was similar (60.4±8.9 versus 58.6±12.0%; 
P=0.10). Compared with other fibroatheroma, TCFA had 
increased areas of fibrous tissue (3.83±1.99 versus 3.01±2.12 
mm2; P=0.03), NC (1.59±0.99 versus 1.03±0.85 mm2; 
P=0.015), dense calcium (1.22±1.31 versus 0.65±0.79 mm2; 
P=0.03), and NC % (20.8±5.1 versus 16.0±7.3%; P=0.049) 
on VH-IVUS.
OCT-defined measures of atherosclerotic plaque composi-
tion also increased with increased stages of plaque progres-
sion, as defined by histology. There was a significant increase 
in % of plaques containing lipid (eg, adaptive intimal thicken-
ing 11.9% versus TCFA 100.0%; P<0.001) and for maximum 
LA (LA
max
 eg, adaptive intimal thickening 8.0±23.7 versus 
TCFA 156.0±75.7°; P<0.001). FCT
min reduced as lesions 
progressed (eg, pathological intimal thickening 156.3±62.1 
versus TCFA 71.8±44.1 μm; P<0.001). Importantly, both 
LA
max
 (156.0±75.7 versus 137.7±82.6°; P=0.62) and FCT
min 
(71.8±44.1 versus 72.6±32.4 μm; P=0.30) were similar when 
TCFA and other fibroatheroma were compared; however, 
the number of frames of OCT with FCT<85 μm was signifi-
cant higher in TCFA (6.5 [1.75–11.0] versus 2.0 [0.0–7.0]; 
P=0.03).
Plaque Classification
Although individual features may differ subtly between TCFA 
and other fibroatheroma on VH-IVUS and OCT, plaque clas-
sification uses a combination of imaging features to define 
plaque type as compared with standard histological defini-
tions (Figures 1 and 2; Methods section of Data Supplement). 
Overall, the prevalence of VH-TCFA was 20.9% and for OCT-
TCFA was 20.2%. The diagnostic accuracies for any fibroath-
eroma and TCFA were 77.5% and 76.5% for VH-IVUS and 
89.0% and 79.0% for OCT, respectively (Figure 4; Table 4), 
with sensitivities to detect TCFA of 63.6% (VH-IVUS) and 
72.7% (OCT). The incorrectly classified TCFA showed sev-
eral common features. For example, 7 of 8 TCFA (87.5%) 
not identified by VH-IVUS were classified as thick-cap fibro-
atheroma, indicating that although VH-IVUS can identify 
large areas of NC, it has difficulty discriminating thin fibrous 
Figure 3. Coregistration between histology and intravascular imaging. Example of a plaque classified as pathological intimal thickening 
on histology (A), with coregistered virtual-histology intravascular ultrasound (VH-IVUS; B) and optical coherence tomography (OCT; C) 
images. Corresponding longitudinal VH-IVUS (D) and OCT (E) pullbacks denoting the location of the plaque within these vessels (yellow 
bar), with a small side-branch (arrow) and large bifurcation (*) used to assist colocalization.
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caps. In contrast, false-positive VH-TCFA identification was 
commonly encountered in regions of calcification, where the 
adjacent plaque composition was incorrectly portrayed as NC 
(Figure 5). Three of six TCFA incorrectly classified by OCT 
had an LA
max
 <90° and 3 of 6 had FCT
min ≥85 μm (Figure 6), 
suggesting that current thresholds for TCFA identification by 
OCT may not be accurate.
Assessment of Specific Imaging Features to Identify 
Advanced Plaques
These results suggest that existing definitions for TCFA using 
VH-IVUS and OCT may lead to misclassification in ≈20% 
of plaques, and we need better indicators of TCFA. NC area 
and % and plaque area were increased in TCFA; we therefore 
assessed the ability of these features to identify any fibroath-
eroma or TCFA by receiver-operating characteristic analysis. 
Confluent NC area (AUC, 0.74; 95% CI, 0.67–0.81 and AUC, 
0.79; 95% CI, 0.72–0.86) and NC percentage (AUC, 0.68; 
95% CI, 0.61–0.76 and AUC, 0.76; 95% CI, 0.68–0.84) were 
moderate predictors of fibroatheroma and TCFA, respectively 
(Figure 7A and 7C). Plaque area (FA: AUC, 0.74; 95% CI, 
0.67–0.80 and TCFA: AUC 0.77; 95% CI, 0.69–0.85) and 
plaque burden (FA: AUC, 0.76; 95% CI, 0.70–0.83 and TCFA: 
AUC, 0.78; 95% CI, 0.70–0.86) had similar predictive abili-
ties to identify any fibroatheroma and TCFA (P>0.05 for all 
comparisons with NC area and %).
Table 2. Virtual-Histology Intravascular Ultrasound Features for Each Plaque Subtype (ROI Numbers are 
Given in Parentheses)
Histological Classification
AIT (n=60) PIT (n=52) FCa (n=32) ThCFA* (n=45) TCFA† (n=22) P Value* vs †
Gray-scale IVUS
  Lumen area, mm2 4.31±1.52 6.52±3.78 6.79±3.04 6.20±2.66 6.96±3.28 0.14
  Minimal luminal area, mm2 3.83±1.43 5.49±3.34 5.59±2.70 5.22±2.25 5.78±2.85 0.24
  Plaque area, mm2 2.67±1.36 6.37±5.26 10.57±5.43 8.42±4.57 10.91±4.82 0.01
  Plaque burden, % 36.7±7.4 44.9±11.6 59.0±11.4 58.6±12.0 60.4±8.9 0.10
Virtual-histology IVUS
  Fib area, mm2 0.52±0.64 2.42±2.80 3.51±2.15 3.01±2.12 3.83±1.99 0.03
  % Fib 51.6±27.7 61.0±19.2 52.1±14.4 53.0±18.6 52.7±11.8 0.24
  FF area, mm2 0.08±0.12 0.60±1.01 1.00±0.85 0.91±0.90 1.11±0.88 0.31
  % FF 6.9±6.5 9.9±7.2 12.2±6.8 13.4±9.0 12.9±6.5 0.56
  NC area, mm2 0.10±0.17 0.61±0.78 1.59±1.24 1.03±0.85 1.59±0.99 0.02
  % NC 7.8±7.3 12.7±7.9 19.1±7.0 16.0±7.3 20.8±5.1 0.049
  DC area, mm2 0.03±0.06 0.17±0.28 1.37±1.59 0.65±0.79 1.22±1.31 0.03
  % DC 3.4±5.5 3.9±4.3 15.6±12.9 10.5±12.0 13.5±10.6 0.26
AIT indicates adaptive intimal thickening; DC, dense calcium; FA, fibroatheroma; FCa, fibrocalcific; FF, fibrofatty; Fib, fibrous; IVUS, 
intravascular ultrasound; NC, necrotic core; PIT, pathological intimal thickening; ROI, regions-of-interest; TCFA, thin-cap fibroatheroma; 
and ThCFA, thick-cap fibroatheroma (data presented are mean±SD).
Table 3. Optical Coherence Tomographic Features for Each Plaque Subtype (ROI Numbers are Given in 
Parentheses)
Histological Classification
AIT (n=59) PIT (n=51) FCa (n=30) ThCFA* (n=45) TCFA† (n=22) P Value* vs †
Lumen area, mm2 3.26±1.67 4.52±3.13 4.94±2.40 4.56±2.57 5.47±3.03 0.28
Minimal luminal area, mm2 2.71±1.44 3.78±2.65 4.05±2.28 3.55±2.23 4.35±2.74 0.31
Lipid, n (%) 7 (11.9) 9 (17.6) 11 (36.7) 39 (86.7) 22 (100.0) 0.16
Mean lipid arc, ° 6.4±18.0 12.4±28.8 28.7±41.7 89.7±49.4 106.2±50.0 0.42
Maximum lipid arc, ° 8.0±23.7 14.8±34.5 36.7±54.9 137.7±82.6 156.0±75.7 0.62
Calcification, n (%) 0 (0.0) 9 (17.6) 24 (80.0) 26 (57.8) 12 (54.5) 0.81
Mean calcium Arc, ° N/A 8.7±19.9 65.1±49.1 37.7±42.3 48.2±61.1 0.22
Maximum calcium Arc, ° N/A 12.2±28.9 99.3±72.9 58.3±71.3 77.5±96.8 0.21
Minimum FCT, μm 97.5±56.6 156.3±62.1 112.7±53.7 72.6±32.4 71.8±44.1 0.30
Continuous frames with 
FCT<85 μm, (n)
N/A N/A N/A 3.0 [0.0–7.0] 6.5 (1.75–11.0) 0.03
AIT indicates adaptive intimal thickening; FCa, fibrocalcific; FCT, fibrous cap thickness; PIT, pathological intimal thickening; ROI, regions-of-
interest; TCFA, thin-cap fibroatheroma; and ThCFA, thick-cap fibroatheroma (data presented are mean±SD, numbers [%] or median [Q1–Q3] 
as appropriate).
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We next assessed the ability of OCT measures to identify 
any fibroatheroma or TCFA (Figure 7B and 7D). Both LA
mean
 
and LA
max
 were excellent discriminators of fibroatheroma and 
TCFA from other lesions (fibroatheroma LA
mean
: AUC, 0.91; 
95% CI, 0.86–0.96 and LA
max
: AUC, 0.92; 95% CI, 0.87–0.97 
and TCFA LA
mean
: AUC, 0.86; 95% CI, 0.80–0.92 and LA
max
: 
AUC, 0.86; 95% CI, 0.81–0.92). The optimal LA
max
 cut-off 
value for fibroatheroma and TCFA identification was 80.0°, 
which gave sensitivity and specificity of 86.7% and 92.1% for 
fibroatheroma and 100.0% and 74.6% for TCFA. For FCT, the 
highest discriminatory power was observed using the number 
of continuous frames with FCT
min ≤85 μm (AUC, 0.83; 95% 
CI, 0.73–0.93).
Combined Imaging for Identification of Advanced 
Plaques
Although both VH-IVUS and OCT can image coronary 
atherosclerosis, the modalities have different capabilities. 
VH-IVUS is good at assessing plaque composition and VH-
IVUS–based plaque classification has been validated pro-
spectively5–7; however, VH-IVUS has limited resolution such 
that thin fibrous caps cannot be directly imaged. In contrast, 
OCT provides high resolution to measure FCT, but has lim-
ited penetration. These complementary capabilities means 
that different combinations of OCT and VH-IVUS parameters 
may improve the ability to discriminate TCFA from other 
Figure 4. Examples of extracellular lipid accumulation and necrotic core correctly identified by intracoronary imaging. Examples of 2 
plaques seen on histology that were correctly identified as containing extracellular lipid accumulations (top) and necrotic core (bottom) 
by both virtual-histology intravascular ultrasound (VH-IVUS) and optical coherence tomography (OCT). High power images (×20) are 
sampled from areas outlined in low power images (×2).
Table 4. Accuracy of Virtual-Histology Intravascular Ultrasound and Optical Coherence Tomographic 
Plaque Classification Compared With Histology
Histological classification
TCFA (n=22) All FA (n=67) FCa (n=30) Other (n=103)
Virtual-histology intravascular ultrasound
  Correctly identified, (n) 14/22 47/67 11/30 92/103
  Sensitivity, (%) 63.6 (36.8–85.4) 70.1 (50.7–85.4) 36.7 (18.3–58.4) 89.3 (74.4–97.1)
  Specificity, (%) 78.1 (64.3–88.4) 81.2 (67.3–91.0) 94.1 (86.1–98.2) 84.5 (67.7–94.7)
  PPV, (%) 26.4 (14.5–41.6) 65.3 (46.7–81.0) 52.4 (26.6–77.2) 86.0 (69.3–95.6)
  NPV, (%) 94.6 (88.2–98.1) 84.4 (70.3–93.5) 89.4 (74.7–97.1) 88.2 (71.7–96.9)
  Diagnostic accuracy, (%) 76.5 (63.9–86.4) 77.5 (66.3–86.4) 85.5 (75.4–92.6) 87.0 (82.6–90.6)
Optical coherence tomography
  Correctly identified, (n) 16/22 55/67 19/30 96/103
  Sensitivity, (%) 72.7 (46.5–90.8) 82.1 (63.6–93.7) 63.3 (39.7–83.0) 93.2 (80.3–98.8)
  Specificity, (%) 79.8 (67.5–89.0) 92.5 (81.0–98.1) 97.6 (88.7–99.9) 82.5 (66.1–93.1)
  PPV, (%) 30.8 (17.9–46.3) 84.6 (67.3–94.9) 82.6 (55.9–96.6) 85.0 (68.2–95.0)
  NPV, (%) 95.9 (90.1–98.8) 91.1 (78.7–97.5) 93.8 (80.5–99.1) 92.0 (76.4–98.6)
  Diagnostic accuracy, (%) 79.0 (67.1–88.1) 89.0 (84.9–92.3) 92.5 (85.8–96.7) 88.0 (82.8–92.1)
Estimates of diagnostic performance are reported with Clopper–Pearson 95% confidence intervals adjusted for clustering. FA indicates 
fibroatheroma; FCa, fibrocalcific; NPV, negative predictive value; PPV, positive predictive value; and TCFA, thin-cap fibroatheroma.
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fibroatheroma (Table 5). Indeed, combining plaque burden 
≥50% and LA
max
≥80° increased sensitivity to 86.4% and diag-
nostic accuracy to 80.5% for TCFA identification, with accu-
racy further increased to 85.0% if VH-defined fibroatheroma 
was also incorporated. However, the highest diagnostic accu-
racy (89.0%) was seen when VH-defined fibroatheroma was 
combined with FCT<85 μm for 3 continuous frames.
Discussion
Identification of advanced coronary plaques at risk of rup-
ture remains a major challenge in cardiovascular research, 
with both VH-IVUS and OCT offering potential solutions. 
Although the accuracy of VH-IVUS for tissue characteriza-
tion exceeds 93.5% in ex vivo studies,3 its diagnostic ability 
to identify TCFA is lower,4 and VH-IVUS studies consistently 
show a higher than anticipated prevalence of TCFA in vivo.5,6 
In contrast, OCT has a higher sensitivity (90% to 92%) to 
identify lipid-rich plaques,9 but initial validation studies were 
often performed in noncoronary arterial territories with older, 
time-domain systems. Our study represents the first direct 
comparison of VH-IVUS and OCT alone and in combination 
for identification of advanced atherosclerotic lesions, com-
pared with histology.
We show that both VH-IVUS and OCT can accurately 
quantify changes in tissue composition as plaques develop, 
including lipid/NC and calcification. Several IVUS and 
VH-IVUS features including plaque and NC areas were 
higher in TCFA versus other fiboratheroma, whereas only the 
number of continuous frames with FCT≤85 μm was higher 
in TCFA on OCT. Using existing definitions, both modalities 
could reliably identify both fibroatheroma and TCFA, with 
the diagnostic accuracy of OCT for TCFA identification mar-
ginally exceeding that of VH-IVUS (79.0% versus 76.5%). 
Importantly, we find that LA
mean
 or LA
max
 can identify TCFA, 
and propose a new cut off of LA
max
 ≥80° that may optimize 
TCFA detection. Finally, we show that combined VH-IVUS 
and OCT features of VH-defined fibroatheroma and FCT<85 
μm over 3 consecutive frames markedly improved TCFA 
identification and led to a drop in the incidence of plaques 
classified as TCFA by imaging.
Our data highlight that both VH-IVUS and OCT can reli-
ably identify fibroatheroma based on existing methods, with 
diagnostic accuracies exceeding 77.5%. Sensitivities were also 
reassuringly high (>70.1%), indicating that both modalities can 
readily identify large accumulations of NC/lipid, an observa-
tion supported by original validation studies assessing plaque 
Figure 5. Examples of plaques incorrectly 
classified as virtual-histology thin-cap fibro-
atheroma (VH-TCFA). A and B, Examples 
of 2 coronary plaques incorrectly classified 
as TCFAs by VH-IVUS. Reasons for mis-
classification include incorrect tissue char-
acterization (A), with an area of intraplaque 
hemorrhage (*) being depicted as necrotic 
core and artifactual regions of necrotic core 
adjacent to a large plate of calcification (B). 
For both plaques, confluent necrotic core 
was >10% and in contact with the luminal 
contour (arrows), resulting in VH-TCFA 
classification. High power images represent 
areas outlined on histology (left).
Figure 6. Example of plaque incorrectly classified as optical 
coherence tomography thin-cap fibroatheroma (OCT-TCFA). 
A–D, Histological image of a fibroatheroma (A) displaying evi-
dence of extracellular lipid accumulation (B) and thick (>65 μm) 
overlying fibrous cap (*) with coregistered OCT image (C). The 
OCT displays a signal-poor region with poorly delineated borders 
(D) correctly identifying lipid, but the minimal fibrous cap thick-
ness (measured at arrow) was <85 μm, resulting in classification 
as OCT-TCFA.
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tissue characterization.3,9 However, we also observed several 
false-positive results with both modalities, suggesting that 
TCFA may be overestimated in vivo. Our observations are sup-
ported by comparisons of clinical and histopathologic studies. 
For example, prospective imaging studies of nonculprit plaques 
have shown that VH-TCFA prevalence ranges from 21.6 to 
60.3%5,6 with OCT-TCFA prevalence of ≈20%.12 In contrast, 
histopathologic studies show that ≈10% of all fibroatheroma 
are TCFA, representing 1.6% of the total coronary tree.8 Thus, 
future improvements toward in vivo TCFA identification should 
aim to reduce the number of false-positive observations.
Central to either fibroatheroma or TCFA identification is 
an objective assessment of overall lipid burden of a plaque 
and assessment of FCT. The limited tissue penetration of OCT 
has resulted in LA being suggested as a surrogate measure of 
plaque lipid area. However, it is unknown whether mean or 
maximal plaque LA should be used, or the threshold required 
for optimal TCFA identification. Clinical studies have used 
varying definitions with LA values between ≥90° and 180°.11,12 
We find that LA
mean
 and LA
max
 are highly correlated and both 
measures produce high AUC statistics for fibroatheroma and 
TCFA identification. Using receiver-operating characteristic 
analysis, we find that LA
max
 of ≥80° provides optimum sen-
sitivity to identify TCFA, compared with thresholds already 
in widespread use. Interestingly, we also observed that the 
number of continuous OCT frames with FCT<85 μm differed 
between TCFA and other fibroatheroma (P=0.03), with no 
observable difference in FCT
min (P=0.30). Indeed, we observed 
that 64.2% of all fibroatheroma had FCT
min <85 μm at some 
location within the plaque, implying that any single-frame 
Figure 7. Receiver-operating curves for identification of advanced coronary plaques. A–D, Receiver-operating curves for the identi-
fication of all fibroatheroma (FA) and thin-cap fibroatheroma (TCFA) using virtual-histology intravascular ultrasound ( (A and C) and 
OCT (B and D).
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measurement of FCT on OCT is unlikely to represent overall 
cap thickness. Quantification of the number of frames with 
FCT<85 μm in a plaque may be more robust measure of cap 
status as it mitigates against erroneous measures within single 
frames that could act to misclassify plaques as TCFA.14 These 
results should help to inform further studies aiming to dis-
criminate TCFA from other plaque subtypes.
Our unique data set allows study of combinations of 
VH-IVUS and OCT imaging features to determine whether 
hybrid imaging could improve overall diagnostic accuracy for 
TCFA. We tested many combinations of VH-IVUS and OCT 
parameters and found that VH-FA and FCT<85 μm <3 con-
secutive frames improved diagnostic accuracy for TCFA to 
89.0%, a level approaching clinical use. Although this com-
bination will inevitably result in occasional false-positive 
observations, it seems significantly better than either imaging 
modality alone and suggests a role for hybrid imaging in ath-
erosclerosis. Indeed, combined VH-IVUS and OCT has been 
previously performed ex vivo15 and in clinical studies,16 with 
both suggesting that imaging artifacts may be reduced through 
hybrid approaches. This position was further strengthened by 
recent autopsy data, highlighting that combined gray-scale 
IVUS and OCT can improve TCFA identification.17 Our study 
adds to this growing literature and seeks to overcome some of 
the limitations of previous autopsy work, where the histologi-
cal prevalence of TCFA was low.15,17 Development of novel 
hybrid imaging catheters is ongoing, and it will be important 
to determine whether these devices improve our prediction of 
future cardiovascular events.
Limitations
There are some limitations to our study. First, we examined 
ROI obtained from 14 hearts and our findings should be vali-
dated in larger data sets; however, this represented 258 coreg-
istered ROI, resulting in robust statistical analysis. Second, 
coregistration between VH-IVUS and OCT is challenging 
and small longitudinal mismatches between imaging modali-
ties may have a minor effect on overall results. However, an 
experienced imaging specialist performed all coregistration 
blinded to histological plaque classification, ensuring that the 
results presented are objective and free from bias. Third, 58 
ROI could not be imaged with both modalities. However, all 
these ROI were located distally with few significant plaques, 
suggesting that overall values for accuracy are unlikely to 
be significantly affected. Fourth, histological processing can 
cause fragmentation and loss of plaque material, particularly 
in heavily calcified regions. Thus, the histological validation 
presented here may not precisely reflect the diagnostic per-
formance of VH-IVUS and OCT in calcified vessels. Finally, 
these current results apply to VH-IVUS only and do not reflect 
the ability of other radiofrequency analysis methods to per-
form plaque classification.
Conclusions
We demonstrate that both VH-IVUS and OCT can reliably 
identify advanced coronary plaques. We suggest refined cut-
off values for TCFA identification for OCT, and find that com-
bined VH-IVUS/OCT markedly improves overall diagnostic 
accuracy. Our results should assist clinicians and researchers 
in planning future studies to identify high-risk plaques in vivo.
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CLINICAL PERSPECTIVE
Advanced atherosclerotic coronary plaques, including thin-cap fibroatheroma (TCFA), are thought to be responsible for the 
majority of myocardial infarctions. Thus, imaging modalities that can identify TCFA in vivo are of considerable importance. 
Virtual-histology intravascular ultrasound and optical coherence tomography (OCT) are invasive imaging modalities that 
can both assess coronary plaque morphology, allowing plaque classification. However, their ability to classify plaques has 
never been directly compared and it remains unknown whether combining these modalities would improve TCFA identifica-
tion. Here, we performed ex vivo imaging of human coronary arteries, investigating whether virtual-histology intravascular 
ultrasound or OCT can perform accurate plaque classification, compared with “gold-standard” histology. We find that using 
existing imaging definitions, both modalities could reliably identify TCFA, with the diagnostic accuracy of OCT marginally 
exceeding that of virtual-histology intravascular ultrasound. In addition, we suggest refined cut-off values for lipid arc and 
fibrous cap thickness on OCT that may improve TCFA identification in vivo. Finally, we demonstrate that hybrid virtual-
histology intravascular ultrasound/OCT imaging has potential to further improve TCFA identification. These results should 
hopefully assist clinicians and researchers in planning future studies to identify high-risk plaques.
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Supplemental Methods 
 
VH-IVUS plaque classification1 
Image    Plaque Subtype Description 
 
Plaque Plaque burden (PB) >40% vessel 
cross-sectional area for 3 consecutive 
frames 
 
Fibroatheroma  
(VH-FA) 
Plaque with >10% confluent necrotic 
core for 3 consecutive frames 
 
Thin-capped fibroatheroma 
(VH-TCFA) 
VH-FA with confluent necrotic core 
in contact with the lumen for 3 
consecutive frames 
 
Fibrocalcific plaque 
(VH-FCa) 
Plaque with >10% dense calcium for 3 
consecutive frames 
 
Pathological intimal  
thickening 
(VH-PIT) 
Plaque not meeting either VH-FA or 
VH-FCa definitions 
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OCT plaque classification2 
 
Image    Plaque Subtype Description 
 
Non-atherosclerotic vessel 
(OCT-NAV) 
Three-layered architecture of the 
vessel wall, with no or little evidence 
of intimal thickening 
 
Plaque 
 
Focal intimal thickening with loss of a 
layered structure to the vessel wall 
 
Fibroatheroma  
(OCT-FA) 
Plaque with evidence of OCT defined 
lipid pool, where LAMax ≥90° 
 
Thin-capped fibroatheroma 
(OCT-TCFA) 
OCT-FA with FCTMin ≤85µm 
 
Fibrocalcific plaque 
(OCT-FCa) 
Plaque with evidence of calcification, 
where any lipid-pool were LAMax ≤90° 
 
Fibrous plaque 
(OCT-Fib) 
Plaque not meeting either OCT-FA or 
OCT-FCa definitions 
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Table S1 VH-IVUS plaque classification inter-observer agreement 
 
 
 
 
 
 
 
 
 
 
 
 
FCa, fibrocalcific; PB, plaque burden; PIT, pathological intimal thickening; ThCFA, thick-cap fibroatheroma; TCFA, thin-cap fibroatheroma 
 
 
 
  Observer A 
  PB<40% PIT FCa ThCFA TCFA Total 
O
bs
er
ve
r 
B
 
PB<40% 55 0 0 0 0 55 
PIT 0 62 0 1 0 63 
FCa 0 1 13 0 0 14 
ThCFA 0 2 4 15 1 22 
TCFA 0 2 9 5 42 58 
Total 55 67 26 21 43 212 
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Table S2 OCT plaque classification inter-observer agreement 
 
  Observer A 
  NAV Fib FCa FA Total 
O
bs
er
ve
r 
B
 
NAV 86 1 0 4 91 
Fib 0 18 1 0 19 
FCa 0 1 23 0 24 
FA 1 4 4 65 74 
Total 87 24 28 69 208 
 
FA, fibroatheroma; FCa, fibrocalcific; Fib, fibrous; NAV, non-atherosclerotic vessel 
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